Does EPTIFIBATIDE Cause Product use in unapproved indication? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Product use in unapproved indication have been filed in association with EPTIFIBATIDE (Eptifibatide). This represents 13.2% of all adverse event reports for EPTIFIBATIDE.
61
Reports of Product use in unapproved indication with EPTIFIBATIDE
13.2%
of all EPTIFIBATIDE reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product use in unapproved indication From EPTIFIBATIDE?
Of the 61 reports, 1 (1.6%) required hospitalization.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPTIFIBATIDE. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does EPTIFIBATIDE Cause?
Thrombocytopenia (58)
Drug ineffective (39)
Off label use (31)
Haemoglobin decreased (30)
Haemorrhage (28)
Vascular stent thrombosis (19)
Condition aggravated (14)
Gastrointestinal haemorrhage (14)
Haematoma (14)
Product use issue (14)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which EPTIFIBATIDE Alternatives Have Lower Product use in unapproved indication Risk?
EPTIFIBATIDE vs EPTINEZUMAB-JJMR
EPTIFIBATIDE vs EPTINEZUMAB\EPTINEZUMAB-JJMR
EPTIFIBATIDE vs EQUINE THYMOCYTE IMMUNE GLOBULIN
EPTIFIBATIDE vs ERAVACYCLINE
EPTIFIBATIDE vs ERBITUX